Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00678600 · ClinicalTrials.gov registry record · NA
Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
A NA study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 1,011
- Enrollment target
- 1
- Study location
NCT00678600: Completed NA study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00678600 is a NA study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,011 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00678600, a NA study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 1,011 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether alerts independent of the ambulatory health record are more effective in eliciting physician responses and therefore have greater impact on HIV disease outcomes than traditional static alerts.
Conditions Studied
Interventions
- OTHER Standard (static) Computer Alerts
- OTHER Enhanced Computer Alerts
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,011 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00678600 record still lists
NCT00678600 is an interventional study that assigns participants to a tested intervention. Its 1,011 participants enrollment target places it among the larger protocols in the corpus, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (128% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Standard (static) Computer Alerts is the first listed.
NCT00678600 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00678600 about?
NCT00678600 is a clinical study titled "Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care". The purpose of this study is to determine whether alerts independent of the ambulatory health record are more effective in eliciting physician responses and therefore have greater impact on HIV disease outcomes than traditional static alerts.
What is the current status of trial NCT00678600?
This trial is currently completed. It is a NA study. The enrollment target is 1,011 participants. The study started on 2007-09. Estimated completion is 2008-12.
What conditions does trial NCT00678600 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00678600?
The interventions under investigation include: Standard (static) Computer Alerts (OTHER), Enhanced Computer Alerts (OTHER).
Who is sponsoring clinical trial NCT00678600?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00678600 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00678600's enrollment target sits among peer trials
1,011 29th of 542 higher than 514 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia